Wird geladen...
Pharmacokinetic and Pharmacodynamic Considerations in the Design of Therapeutic Antibodies
The design and development of therapeutic monoclonal antibodies (mAbs) through optimizing their pharmacokinetic (PK) and pharmacodynamic (PD) properties is crucial to improve efficacy while minimizing adverse events. Many of these properties are interdependent, which highlights the inherent challeng...
Gespeichert in:
| Veröffentlicht in: | Clin Transl Sci |
|---|---|
| Hauptverfasser: | , |
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
John Wiley and Sons Inc.
2018
|
| Schlagworte: | |
| Online Zugang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6440574/ https://ncbi.nlm.nih.gov/pubmed/30414357 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/cts.12597 |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|